Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons drs. M.H. Pronk

Publicaties

A Dutch cost-effectiveness analysis of fremanezumab versus best supportive care in patients with chronic migraine and inadequate response to prior preventive therapy